US IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%;...read more
Phillips 66 Partners LP, a Phillips 66-backed limited partnership that owns pipeline and logistics assets, raised $378 million by offering 16.4 million shares at $23, above the range of $19-$21. The company had originally planned to sell 15 million shares....read more
Last week was a busy week for US IPOs, with seven deals pricing and five more setting terms. OncoMed (OMED) delivered last week's best performing deal, gaining 60% on its first day of trading, the best first-day return for a biotech since July 2000. Activity...read more
US IPO Recap: 11 deals price in busiest week since November 2007, eight companies set terms
US IPOs continued to make a strong showing this week, with 11 deals raising an aggregate of $1.6 billion in proceeds. It was the busiest week since the week of November 5, 2007, which saw 13 pricings. Performance was mixed, with an average total return of 7%;...read more
Phillips 66 Partners LP prices upsized IPO at $23.00, above the range
Phillips 66 Partners LP, a Phillips 66-backed limited partnership that owns pipeline and logistics assets, raised $378 million by offering 16.4 million shares at $23, above the range of $19-$21. The company had originally planned to sell 15 million shares....read more
US IPO Recap: Seven deals price, five set terms as busy July continues
Last week was a busy week for US IPOs, with seven deals pricing and five more setting terms. OncoMed (OMED) delivered last week's best performing deal, gaining 60% on its first day of trading, the best first-day return for a biotech since July 2000. Activity...read more
12 US IPOs planned for the week of Jul 22
The following IPOs are expected to price this week: Agios Pharmaceuticals (AGIO), a biotech developing metabolic treatments for cancer and rare genetic diseases, plans...read more